Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1911 1
1912 1
1917 1
1918 1
1919 2
1922 1
1923 2
1925 1
1929 1
1931 1
1934 3
1935 3
1936 4
1937 3
1940 1
1946 1
1947 4
1948 6
1949 3
1950 5
1951 4
1952 6
1953 4
1954 3
1955 5
1956 3
1957 3
1958 4
1959 8
1960 4
1961 3
1962 5
1963 6
1964 8
1965 7
1966 6
1967 5
1968 7
1969 3
1970 8
1971 8
1972 6
1973 7
1974 7
1975 9
1976 9
1977 3
1978 4
1979 5
1980 4
1981 3
1982 2
1983 1
1984 2
1985 3
1986 5
1987 4
1988 4
1989 6
1990 11
1991 5
1992 5
1993 5
1994 4
1995 3
1996 9
1997 8
1998 2
1999 6
2000 6
2001 3
2002 4
2003 4
2004 6
2005 7
2006 101
2007 40
2008 22
2009 17
2010 11
2011 21
2012 18
2013 19
2014 18
2015 25
2016 33
2017 28
2018 28
2019 32
2020 26
2021 24
2022 14
2023 20
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

799 results

Results by year

Filters applied: . Clear all
Page 1
Exostosin 1/Exostosin 2-Associated Membranous Nephropathy.
Sethi S, Madden BJ, Debiec H, Charlesworth MC, Gross L, Ravindran A, Hummel AM, Specks U, Fervenza FC, Ronco P. Sethi S, et al. Among authors: gross l. J Am Soc Nephrol. 2019 Jun;30(6):1123-1136. doi: 10.1681/ASN.2018080852. Epub 2019 May 6. J Am Soc Nephrol. 2019. PMID: 31061139 Free PMC article.
Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention.
Sibbing D, Aradi D, Alexopoulos D, Ten Berg J, Bhatt DL, Bonello L, Collet JP, Cuisset T, Franchi F, Gross L, Gurbel P, Jeong YH, Mehran R, Moliterno DJ, Neumann FJ, Pereira NL, Price MJ, Sabatine MS, So DYF, Stone GW, Storey RF, Tantry U, Trenk D, Valgimigli M, Waksman R, Angiolillo DJ. Sibbing D, et al. Among authors: gross l. JACC Cardiovasc Interv. 2019 Aug 26;12(16):1521-1537. doi: 10.1016/j.jcin.2019.03.034. Epub 2019 Jun 12. JACC Cardiovasc Interv. 2019. PMID: 31202949 Free article. Review.
Psychedelics, With a Focus on Psilocybin: Issues for the Clinician.
Garakani A, Alexander JL, Sumner CR, Pine JH, Gross LS, Raison CL, Aaronson ST, Baron DA. Garakani A, et al. Among authors: gross ls. J Psychiatr Pract. 2023 Sep 1;29(5):345-353. doi: 10.1097/PRA.0000000000000729. J Psychiatr Pract. 2023. PMID: 37678363 Review.
Exhaled Nitric Oxide: An Update.
Hoyte FCL, Gross LM, Katial RK. Hoyte FCL, et al. Among authors: gross lm. Immunol Allergy Clin North Am. 2018 Nov;38(4):573-585. doi: 10.1016/j.iac.2018.06.001. Epub 2018 Sep 21. Immunol Allergy Clin North Am. 2018. PMID: 30342580 Review.
Putting placebos to the test.
Gross L. Gross L. PLoS Biol. 2017 Feb 21;15(2):e2001998. doi: 10.1371/journal.pbio.2001998. eCollection 2017 Feb. PLoS Biol. 2017. PMID: 28222121 Free PMC article. Review. No abstract available.
Conservation stories from the front lines.
Gross L, Hettinger A, Moore JW, Neeley L. Gross L, et al. PLoS Biol. 2018 Feb 5;16(2):e2005226. doi: 10.1371/journal.pbio.2005226. eCollection 2018 Feb. PLoS Biol. 2018. PMID: 29401208 Free PMC article. No abstract available.
Tapinarof validates the aryl hydrocarbon receptor as a therapeutic target: A clinical review.
Silverberg JI, Boguniewicz M, Quintana FJ, Clark RA, Gross L, Hirano I, Tallman AM, Brown PM, Fredericks D, Rubenstein DS, McHale KA. Silverberg JI, et al. Among authors: gross l. J Allergy Clin Immunol. 2023 Dec 27:S0091-6749(23)02547-2. doi: 10.1016/j.jaci.2023.12.013. Online ahead of print. J Allergy Clin Immunol. 2023. PMID: 38154665 Free article. Review.
[Cardiological diseases].
Gross L, Massberg S, Sibbing D. Gross L, et al. Internist (Berl). 2013 Oct;54(10):1171-84. doi: 10.1007/s00108-013-3294-8. Internist (Berl). 2013. PMID: 24005787 German.
Proprotein convertase subtilisin/kexin type 6 (PCSK6) is a likely antigenic target in membranous nephropathy and nonsteroidal anti-inflammatory drug use.
Sethi S, Casal Moura M, Madden B, Debiec H, Nasr SH, Larsen CP, Gross L, Negron V, Singh RD, Nath KA, Storey AJ, Specks U, Fervenza FC, Ronco P, Caza TN. Sethi S, et al. Among authors: gross l. Kidney Int. 2023 Aug;104(2):343-352. doi: 10.1016/j.kint.2023.04.006. Epub 2023 Apr 28. Kidney Int. 2023. PMID: 37119877 Free article.
799 results